First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

标题
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
作者
关键词
-
出版物
NEW ENGLAND JOURNAL OF MEDICINE
Volume 371, Issue 23, Pages 2167-2177
出版商
New England Journal of Medicine (NEJM/MMS)
发表日期
2014-12-04
DOI
10.1056/nejmoa1408440

向作者/读者发起求助以获取更多资源

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started